NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/30/2026
Back to search
Official data from USPTO
ATON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
07/30/2026
Trademark type
Word
Nice classes
1, 5, 42
Filing date
12/08/2023
Registration date
04/08/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/08/2025
Last transaction
07/30/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
FR
Examiner
HUSSAIN, TASNEEM
Law office
M90
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
HYBRIGENICS SA
Representatives
Jeffrey H. Handelsman Greenblum & Bernstein, P.L.C.
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical productschemical additiveschemical active ingredientschemical solventschemical reagentschemical preservativeschemical antioxidantsethylene oxideethylene glycolchlorine for use in the manufacture of pharmaceuticals; active chemical ingredients intended for the manufacture of medicines for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes; biological preparations other than for medical or veterinary use; biological tissue cultures other than for medical or veterinary purposes; cultures of microorganisms other than for medical or veterinary use; stem cells other than for medical or veterinary use; protein being raw material for scientific and medical research; vitamins for manufacturing pharmaceutical products; chemical reagents other than for medical or veterinary use; diagnostic reagents for in-vitro use in biochemistryclinical chemistry and microbiology other than for medical use; chemical reagents for developing monoclonal antibodies other than for medical or veterinary use; monoclonal antibodies for diagnostic usefor scientific purposes other than medical; monoclonal antibodies for industrial scientific research use; chemical substances for analyses in laboratoriesother than for medical or veterinary purposes intended for the biotechnology industry
Class 5
Pharmaceutical products for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes; chemical pharmaceutical preparations for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes; veterinary products for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes; sanitary sterilizing preparations; chemical preparations for pharmaceutical use for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes; chemical preparations for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes for medical use; chemical preparations for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes for veterinary use; pharmaceutical products for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes; biologicalbiochemical and biotechnological preparations for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes for medical use; medicines for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes for human useremedies for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes for human use; medicines for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes for veterinary useremedies for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes for veterinary use; stem cells for medical use; stem cells for veterinary use; biological tissue cultures for medical use; biological tissue cultures for veterinary use; cultures of micro-organisms for medical use; skin grafts being living tissues; surgical implants made of living tissue; antibodies; diagnostic preparations for medical use; diagnostic preparations for veterinary use; in-vitro diagnostic preparations for medical use; biotechnological preparations for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes for medical use; chemical reagents for medical and veterinary use; diagnostic biomarking reagents for medical use; antibiotics
Class 42
Scientific and industrial research and development of vaccines and medicines; engineering; product research and development in industrial processes; product research and development concerning the automation of industrial processes; surveyingengineering work; biological research; medical research; chemical research; scientific laboratory services; laboratory services for medical research; scientific laboratory services for studiesresearch and analysis in the field of chemistry and biology; scientific and technological research relating to patent mapping; research and development in the field of antibodies; research and development in the field of microorganisms and cells; research and development in the field of biochemistry and biotechnology; information about scientific research in the field of biochemistry and biotechnology; technological consultancy services in the technology field of biotechnology and medical technologies; scientific research in the nature of conducting clinical trials for others; testing of materials; scientific and industrial researchfine tuning industrial processestroubleshooting of industrial process control computer software problemsdata automation using proprietary software to evaluateanalyze and collect service dataprofessional scientific consultancymaterial testingscientific laboratory servicescomputer programmingall these services being dedicated to biologybioinformaticsbiochemistrybiotechnologypharmacyproteomicsgenomicscosmetics and agronomy; industrial and scientific research services in the field of molecular biology and more specifically genomicsproteomicsprotein screening and protein interaction research; scientific research and analysis in the field of genetics and genetic engineering and in the field of chemical reagents; research and development of new products for third parties; development and maintenance of computer platforms in the field of the pharmaceutical industry and biotechnology; computer platform as a service PaaS featuring software for scientific analysis and research in the field of the pharmaceutical industry and biotechnology; software engineering services for data processing in the field of the pharmaceutical industry and biotechnology; computer programming services for data processing in the field of the pharmaceutical industry and biotechnology; developing and hosting databases in the field of the pharmaceutical industry and biotechnology; scientific data analysis in the field of the pharmaceutical industry and biotechnology; electronic storage of data in the field of the pharmaceutical industry and biotechnology; engineering services for developing computer data banks in the field of the pharmaceutical industry and biotechnology; developing and providing online non-downloadable computer software platforms for scientific analysis and research and antibody data bankdata warehousing
Publications
History of USPTO decisions and trademark events.
33 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/14/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/15/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/15/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/29/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
10/29/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/25/2025
FIMP
FINAL DISPOSITION PROCESSED
10/24/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/09/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/08/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
04/08/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/18/2025
PUBO
PUBLISHED FOR OPPOSITION
02/18/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/12/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/29/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/27/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/27/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/27/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/27/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/27/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/27/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/27/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/27/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/27/2025
RFNT
REFUSAL PROCESSED BY IB
08/25/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/02/2024
RFRR
REFUSAL PROCESSED BY MPU
08/02/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/11/2024
CNRT
NON-FINAL ACTION WRITTEN
07/10/2024
DOCK
ASSIGNED TO EXAMINER
07/09/2024
MAFR
APPLICATION FILING RECEIPT MAILED
06/01/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/01/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/30/2024
Continuous trademark protection
Get notified about every new filing that threatens ATON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.